menu

FREESPIRA IS THE ONLY PRODUCT PROVEN TO SIGNIFICANTLY REDUCE OR ELIMINATE PANIC ATTACKS AND PTSD SYMPTOMS BY TRAINING USERS TO NORMALIZE RESPIRATORY IRREGULARITIES.

Read our white paper: It’s Not “All in Your Head”
A physiological approach to treating panic attacks and PTSD

Download White Paper

FREEDOM FROM PANIC ATTACKS AND PTSD IN 28-DAYS

Free from panic attacks in 28 days

Free from panic attacks in 28 days

86%1 of patients treated with Freespira were panic attack-free immediately post treatment and 79%1 remained panic attack-free 12 months post treatment.

Learn About Freespira for Panic Attacks

After using Freespira I have been able to manage my stress and anxiety and panic attacks feel like a distant memory. I’m excited to help others live a panic free life as well.

~ Talia

Free from PTSD Symptoms in 28 days

Free from PTSD Symptoms in 28 days

89%2 of patients treated with Freespira had a clinically significant reduction in symptoms and 50%2 were in remission six months post-treatment

Learn About Freespira for PTSD

PTSD disrupts the daily lives of millions of Americans. Yet, traditional medication and counseling therapies often fall short for these sufferers – many of whom have begun to believe that there is no hope for relief or remission. Innovative drug-free approaches, like Freespira, that address the underlying physiological symptoms of PTSD provide a new solution – and new hope – to this problem.”

~ Honorable David J. Shulkin, M.D., Ninth Secretary of the US Department of Veterans Affairs

Learn About Freespira for PTSD
Reduce Behavioral Health Costs

Reduce Behavioral Health Costs

Panic disorder and PTSD have a high cost on quality of life and the bottomline. Freespira is a one-time investment that can eliminate panic attacks and PTSD symptoms long after treatment ends.

Learn How Freespira Lowers Costs

*Freespira is indicated (FDA-cleared) as an adjunctive treatment of symptoms associated with panic disorder, panic attacks and/or PTSD in patients 18 and older. In younger patients, Freespira has been evaluated and is being made available as permitted by FDA’s COVID-19 Enforcement Discretion Guidance.

1 Vol.:(0123456789)1 3 Applied Psychophysiology and Biofeedback https://doi.org/10.1007/s10484-020-09465-0, Evaluating the Impact of Freespira on Panic Disorder Patients’ Health Outcomes and Healthcare Costs within the Allegheny Health Network, Alicia Kaplan · Anthony P. Mannarino · P. V. Nickell

2 Ostacher MJ*, Investigation of the Freespira System in the treatment of PTSD. Submitted for publication. CAPS-5 = Clinician-Administered PTSD Scale for DSM-5; *Reliable change index